McKnight's Long-Term Care News

FDA: First-of-its-kind diagnostic test for Alzheimer’s gets green light

The first in vitro diagnostic test to detect brain plaques tied to Alzheimer’s disease can now be marketed to clinicians, the Food and Drug Administration announced this week. The Lumipulse G ...
Hosted on MSN

New light-based technique promises advances in non-invasive medical diagnostics

An Aston University researcher has developed a new technique using light which could revolutionize non-invasive medical diagnostics and optical communication. The research showcases how a type of ...
WTHR

Roche Diagnostics gets OK from FDA to mass-produce at-home COVID-19 test

That’s how many rapid COVID-19 tests Indianapolis-based Roche Diagnostics plans to make, now that they have the green light from the Food and Drug Administration. The FDA granted emergency use ...
Business Wire

Anavasi Diagnostics Receives FDA Emergency Use Authorization for The AscencioDx COVID-19 Test and The AscencioDx Molecular Detector

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...
Odessa American

Universal Diagnostics Presents Promising Data on Lung Cancer Detection using Blood-Based Methylation Test at the IASLC 2020 World Conference on Lung Cancer

Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced today promising new data for its investigational ...